Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01390259 · ClinicalTrials.gov registry record · NA

Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Control to Range System

A NA study, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
11
Enrollment target

NCT01390259: Completed NA study, sponsored by University of Virginia.

NCT01390259 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01390259, a NA study, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target

Study Summary

In this protocol the investigators plan to demonstrate management of glucose using a modular insulin management system based on continuous glucose monitoring and targeted towards the avoidance of hypoglycemic and prolonged hyperglycemic episodes (i.e. control to range). The protocol is designed to challenge the insulin management system with meals and mild exercise, so as to demonstrate its capacity to avoid large glucose excursion with changing metabolic state. This system is designed to both * monitor the meal boluses of the patient and correct it in case of observed/predicted under insulinization (avoidance of prolonged hyperglycemia), based on a coarse and subjective knowledge of the meal amount, a precise understanding of the subject's day to day insulin treatment, continuous glucose monitoring, and past insulin injections; * predict and avoid hypoglycemic events, based on continuous glucose reading and past insulin injection. The investigators plan to enroll 12 adolescent T1DM patients (expected retention 10/12) and compare glucose control performances under two treatments: standard vs. the new insulin management system. The protocol will include a total of 5 admissions per subject (3 out-patients and 2 in-patients): screening, CGM insertion 1, CGM insertion 2, inpatient 1 and inpatient 2. During the 24h inpatient admissions the patients will be challenged with 30 minutes of mild exercise and 3 meals, insulin coverage of these events will vary depending on the chosen treatment, each subject will be exposed to both studied treatments (repeated measure design). The order of treatment during the inpatient admissions will be randomized.

Primary Outcome

Number of hypoglycemic events below 70 mg/dL per patient per day Hypoglycemic event is defined as consecutive YSI plasma glucose measurements below 70 or moderate hypoglycemic symptoms

Interventions

  • DEVICE Open-Loop
  • DEVICE Closed-Loop

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2010-01
Est. Completion 2011-02
Phase NA
University of Virginia

449 total trials

What the finished NCT01390259 record still lists

NCT01390259 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Open-Loop is the first listed.

NCT01390259 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01390259 about?

NCT01390259 is a clinical study titled "Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Control to Range System". In this protocol the investigators plan to demonstrate management of glucose using a modular insulin management system based on continuous glucose monitoring and targeted towards the avoidance of hypoglycemic and prolonged hyperglycemic episodes (i.e. control to range). The protocol is designed to c...

What is the current status of trial NCT01390259?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2010-01. Estimated completion is 2011-02.

What interventions are being tested in trial NCT01390259?

The interventions under investigation include: Open-Loop (DEVICE), Closed-Loop (DEVICE).

Who is sponsoring clinical trial NCT01390259?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01390259's enrollment target sits among peer trials

11 1927th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01390259, the US trial registry maintained by the National Library of Medicine. NCT01390259 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.